NFKB1 and common variable immunodeficiency: Only four patients suspected to have CVID received a molecular diagnosis (CTLA4, SH2D1A, NFKB1, LRBA), and one patient was identified as a heterozygous carrier of a TACI pathogenic mutation, which is not diagnostic alone, but is considered a risk factor for CVID.